贝特类药物及烟酸在糖尿病心血管并发症防治中的应用
被引量：1
摘要
随着社会经济的发展，糖尿病已成为全球性的流行病，发病率显著增长。中国糖尿病的发病率近10年增长了10倍，居全球第2位。糖尿病及其并发症给社会带来巨大的负担。
出处
《内科理论与实践》
2008年第5期307-310,共4页
Journal of Internal Medicine Concepts & Practice
参考文献10
-
1The Bezafibrate Infarction Prevention(BIP)study.Se-condary prevention by raising HDL cholesterol and redu-cing triglycerides in patients with coronary artery disease[].Circulation.2000
-
2Keech A,,Simes RJ,Barter P,et al.Effects of long-term fenofibrate therapy on cardiovascular events in9795people with type2diabetes mellitus(the FIELD study):randomised controlled trial[].The Lancet.2005
-
3Elam MB,Hunninghake DB,Davis KB,et al.Effect of niacin on lipid and lipoprotein levels and glycemic con-trol in patients with diabetes and peripheral arterial di-sease:the ADMIT study,a randomized trial[].The Journal of The American Medical Association.2000
-
4ACCORD Study Group.Action to Control Cardiovascular Risk in Diabetes(ACCORD)trial:design and methods[].The American Journal of Cardiology.2007
-
5Taylor AJ,Lee HJ,Sullenberger LE.The effect of24months of combination statin and extended-release niacin on carotid intima-media thickness:ARBITER3[].Current Medical Research and Opinion.2006
-
6Turner RC,Millns H,Neil HA,et al.Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus:United Kingdom Prospective Diabetes Study(UKPDS:23)[].British Medical Journal.1998
-
7Garvey WT,Kwon S,Zheng D,et al.Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance[].Diabetes.2003
-
8Frick MH,Elo O,Haapa K,et al.Helsinki Heart Study:primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia Safety of treatment,changes in risk factors,and incidence of coronary heart disease[].The New England Journal of Medicine.1987
-
9.
-
10GrundySM,Vega GL,McGovern ME,et al.Efficacy,safety,and toler-ability of once-daily niacin for the treatment of dyslipidemia associ-ated with type2diabetes:results of the assessment of diabetes control and evaluation of the efficacy of niaspan trial[].Archives of Internal Medicine.2002
同被引文献34
-
1赵笃英,李平,杜晋花.酚妥拉明与香丹注射液合用治疗糖尿病周围神经病变的疗效观察[J].实用糖尿病杂志,2005,13(1):37-38. 被引量：5
-
2程赣萍,王桥根,应卫婵,王晓翔,邵锦根,张耀西.依达拉奉治疗糖尿病周围神经病变临床观察[J].中国药物与临床,2006,6(1):74-75. 被引量：12
-
3谷立杰,黄一新.糖尿病肾病药物治疗研究进展[J].国际泌尿系统杂志,2006,26(5):696-701. 被引量：2
-
4杨廷强,朱瑾,李秀钧.大剂量甲钴胺治疗糖尿病周围神经病变疗效观察[J].华西医学,2007,22(1):131-132. 被引量：34
-
5王月丽.前列地尔治疗DPN 42例临床观察[J].实用糖尿病杂志,2007,3(2):20-21. 被引量：4
-
6Flint H,Cotter MA,Cameron NE.Pentoxifylline effects on nerve conduction velocity and blood flow in diabetic rats[J].Int J Exp Diabetes Res,2000,1(1):49-58.
-
7Tamarat R,Silvestre JS,Huijberts M,et al.Blockade of advanced glycation end-product formation restores ischemia-induced angiogenesis in diabetic mice[J].Proc Natl Acad Sci USA,2003,100(14):8555-8560.
-
8Ikeuchi H,Kuroiwa T,Yamashita S,et al.Fluvastatin reduces renal fibroblast proliferation and production of type III collagen:Therapeutic implications for tubulointerstitial fibrosis[J].Nephron Exp Nephrol 2004,97(4):115-122.
-
9Ludirigser E,Olsson R,Stridsberg M,et al.Expression and distribution of somatostatin receptor subtypes in the pancreatic islets of mice and rats[J].Journal of Histochemistry and Cytochemistry,2004,52(3):391-400.
-
10Bolton WK,Cattran DC,Williams ME,et al.Wuerth JP:Randomized trial of an inhibitor of formation of advanced glycation end products in diabetic nephropathy.[J].Am J Nephrol,2002,24(1):32-40.
二级引证文献15
-
1梁霄.糖化血红蛋白与空腹血糖联合检测的临床意义及其相关性探讨[J].临床误诊误治,2011,24(11):87-88. 被引量：17
-
2梁霄.糖化血红蛋白检测在糖尿病及其并发症诊断和治疗中的应用[J].临床合理用药杂志,2011,4(19):89-90. 被引量：1
-
3梁霄.糖化血红蛋白检测对糖尿病诊治的临床研究[J].临床合理用药杂志,2012,5(4):108-108. 被引量：5
-
4诊断[J].医药前沿,2012(10):49-49.
-
5刘林刚.糖尿病合并肺结核112例临床分析[J].中国医药导刊,2012,14(7):1272-1272. 被引量：1
-
6吴宏.糖尿病及其并发症的防治措施[J].医学信息,2013(6):417-417.
-
7江桂芳,李晓红.高压氧辅助治疗糖尿病合并压疮患者的疗效观察[J].中国现代药物应用,2013,7(13):175-176. 被引量：2
-
8徐庆锋.糖化血红蛋白检测糖尿病诊治中的临床价值[J].齐齐哈尔医学院学报,2013,34(16):2412-2414. 被引量：5
-
9杨海英.空腹血糖及其联合糖化血红蛋白检测在糖尿病早期诊断中的临床价值探讨[J].中国医药指南,2013,11(36):414-415. 被引量：1
-
10韩玉坤,杨阳,刘玉翠,金嵩,臧琳,朱天信,齐玲.大蒜素对Ⅱ型糖尿病发生发展的影响及作用机制[J].吉林医药学院学报,2014,35(4):297-299.
-
1张春梅,杨焕东,王慎田.生长激素与糖尿病血管并发症[J].医学综述,2002,8(4):241-243. 被引量：1
-
2马长红,李鸿雁,谭那,田永霞.动态血压监测与糖尿病微血管病变关联性研究[J].陕西医学杂志,2015,44(12):1669-1670. 被引量：2
-
3周丽华,林小红,孟晓军.高敏C反应蛋白与2型糖尿病下肢血管病变的关系[J].医学临床研究,2011,28(2):279-280. 被引量：2
-
4吴沛田.糖尿病血管病变中医辨治应注意什么?[J].中医杂志,2007,48(1):86-86.
-
5傅冷西,张小凯,陈红.胰岛素自身抗体与胰岛素抵抗的关系[J].福建医科大学学报,2002,36(1):73-74. 被引量：1
-
6耿纪录,杨子姜,戴富林.糖尿病血管重构及其防治[J].天津医药,2000,28(1):62-64. 被引量：31
-
7梁力晖.C反应蛋白在2型糖尿病大血管病变患者中的表达及意义[J].医学临床研究,2012,29(6).
-
8李文星,刘建国,周顺延,赵术忠,丁素银.脉络宁联合微波治疗糖尿病下肢血管病变30例疗效观察[J].疑难病杂志,2008,7(9):548-549. 被引量：1
-
9吴玉泉,王静.糖尿病大血管病变发病机制的研究[J].医学综述,2004,10(3):175-177. 被引量：4
-
10林东平,吴万龄.40例糖尿病患者血栓形成前期若干相关指标的变化[J].中日友好医院学报,1999,13(5):267-269.
